Results 131 to 140 of about 7,404 (210)

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels. [PDF]

, 2018
BRCA1/2 mutations are significant risk factors for hereditary breast and ovarian cancer (HBOC), its mutation frequency in HBOC of Chinese ethnicity is around 9%, in which nearly half are recurrent mutations.
Chan, Tsun L, Domchek, Susan M, Esserman, Laura J, Field, Michael, Ford, James M, Ho, John CW, Kurian, Allison W, Kwong, Ava, Lin, Po-Han, Lo, Jessica, Ma, Edmond SK, Ngan, Hextan YS, Shin, Vivian Y, Tai, Edmund, Weitzel, Jeffery N   +14 more
core  

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. [PDF]

BJOG, 2023
Nebgen DR, Domchek SM, Kotsopoulos J, de Hullu JA, Crosbie EJ, Paramanandam VS, Brood-van Zanten MMA, Norquist BM, Guise T, Rozenberg S, Kurian AW, Pederson HJ, Yuksel N, Michaelson-Cohen R, Bober SL, da Silva Filho AL, Johansen N, Guidozzi F, Evans DG, Menon U, Kingsberg SA, Powell CB, Grandi G, Marchetti C, Jacobson M, Brennan DJ, Hickey M.   +26 more
europepmc   +1 more source

Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial. [PDF]

Cancer Med, 2023
Metcalfe KA, Pal T, Narod SA, Armel S, Shickh S, Buckley K, Walters ST, Brennenstuhl S, Kinney AY.   +8 more
europepmc   +1 more source

Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy [PDF]

, 2018
Our objective was to estimate the incidence and identify the risk factors for vaginal vault prolapse repair after hysterectomy. We conducted a case control study among 6,214 women who underwent hysterectomy from 1982 to 2002.
Boulvain, Michel, Dubuisson, Jean-Bernard, Dällenbach, Patrick, Jacob, Sandrine, Kaelin-Gambirasio, Isabelle   +4 more
core  

Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan. [PDF]

Sci Rep, 2023
Nomura H, Abe A, Fusegi A, Yoshimitsu T, Misaka S, Murakami A, Matsumoto T, Tsumura S, Kanno M, Aoki Y, Netsu S, Omi M, Tanigawa T, Okamoto S, Omatsu K, Yunokawa M, Kanao H, Habano E, Arakawa H, Kaneko K, Ueki A, Haruyama Y, Inari H, Ueno T.   +23 more
europepmc   +1 more source

Population testing for cancer predisposing BRCA1/BRCA2 mutations [PDF]

, 2014
Background: Technological advances raise the possibility of systematic population-based genetic testing for cancer-predisposing mutations, but it is uncertain whether benefits outweigh disadvantages.
Wardle, J
core  

Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy. [PDF]

BMJ Case Rep, 2023
Kojima R, Toyoshima M, Yamamoto A, Suzuki S.   +3 more
europepmc   +1 more source

SEOM clinical guidelines in Hereditary Breast and ovarian cancer [PDF]

, 2015

core   +1 more source

TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol. [PDF]

Int J Gynecol Cancer, 2023
Steenbeek MP, van Bommel MHD, intHout J, Peterson CB, Simons M, Roes KCB, Kets M, Norquist BM, Swisher EM, Hermens RPMG, TUBA-WISP II consortium, Lu KH, de Hullu JA.   +12 more
europepmc   +1 more source

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a BRCA1 or BRCA2 Germline Pathogenic Variant. [PDF]

Cancers (Basel), 2023
Stuursma A, van der Vegt B, Jansen L, Berger LPV, Mourits MJE, de Bock GH.   +5 more
europepmc   +1 more source